---  
layout: startup_page  
title: "Refoxy Pharmaceuticals"  
id: "refoxy.com"  
permalink: "/refoxypharmaceuticalsrefoxy.com12042024/"  
website: "https://www.refoxy.com/"  
funding_round: "Seed+"  
funding_amount: "€9.1M"  
investors: "Boehringer Ingelheim Venture Fund (BIVF), Apollo Health Ventures, NRW Venture, High-Tech Gründerfonds (HTGF)"  
about: "Refoxy Pharmaceuticals is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases. Its F.act finder platform identifies molecules modulating FOXO3 for therapeutic effects, initially focusing on fibrotic disorders like idiopathic pulmonary fibrosis (IPF). The company aims to leverage FOXO3's ability to combat cellular stress for novel therapeutics."  
markets: "Biotech, Pharmaceuticals"  
hq: "Cologne, Germany, Europe"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/refoxy-pharma/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/refoxy-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/472022-83"  

date_display: "04-Dec-2024"  
date: "2024-12-04"

# SEO Optimization  
meta_title: "Refoxy Pharmaceuticals - Seed+ Funding (€9.1M)"  
meta_description: "Refoxy Pharmaceuticals, Refoxy Pharmaceuticals is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related di..."  
meta_keywords: "Refoxy Pharmaceuticals, Biotech, Pharmaceuticals, Seed+ funding"  
canonical_url: "https://startup.projectstartups.com/refoxypharmaceuticalsrefoxy.com12042024/"  
---